PHARMABLOCK

300725
40.065.59% ( -2.37 )
Delay Closed: Nov 18, 15:00:00

Profile

About

PHARMABLOCK
PHARMABLOCK
300725.SZ

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support.

Profile

Company Name
PharmaBlock Sciences (Nanjing), Inc.
Market
SZSE
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management